Coronavirus Hasn’t Sparked CURE ID Physician Social Network Interest
Executive Summary
US FDA/NIH smartphone app is intended to allow clinicians and others to talk about potential treatments for infectious diseases, but so far COVID-19-related activity has been limited.
You may also be interested in...
CURE ID Expands Into COVID-19; Oncology And Rare Diseases Are Next
After slow start early in SARS-CoV-2 pandemic, CURE ID now has more than 150 case reports of drugs to treat the coronavirus.
Real-World Evidence On COVID-19: US FDA Approaching With 'Sense Of Urgency'
Agency is going outside its ‘comfort zone’ to leverage different streams of existing real-world data sources to quickly assess the impact of potential treatment approaches, Amy Abernethy says; pandemic experience could lead to a more open embrace of RWE beyond the current public health emergency.
AnGes Takes DNA Vaccine Tack As It Enters Virus R&D Fray
Japanese bioventure goes down the DNA vaccine route, along with several others worldwide, pointing to potential development speed and safety advantages.